147 related articles for article (PubMed ID: 17409447)
1. Parthenolide inhibits tubulin carboxypeptidase activity.
Fonrose X; Ausseil F; Soleilhac E; Masson V; David B; Pouny I; Cintrat JC; Rousseau B; Barette C; Massiot G; Lafanechère L
Cancer Res; 2007 Apr; 67(7):3371-8. PubMed ID: 17409447
[TBL] [Abstract][Full Text] [Related]
2. Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition.
Whipple RA; Vitolo MI; Boggs AE; Charpentier MS; Thompson K; Martin SS
Breast Cancer Res; 2013; 15(5):R83. PubMed ID: 24028602
[TBL] [Abstract][Full Text] [Related]
3. Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis.
Mialhe A; Lafanechère L; Treilleux I; Peloux N; Dumontet C; Brémond A; Panh MH; Payan R; Wehland J; Margolis RL; Job D
Cancer Res; 2001 Jul; 61(13):5024-7. PubMed ID: 11431336
[TBL] [Abstract][Full Text] [Related]
4. Microtubule-interfering activity of parthenolide.
Miglietta A; Bozzo F; Gabriel L; Bocca C
Chem Biol Interact; 2004 Oct; 149(2-3):165-73. PubMed ID: 15501437
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tubulin detyrosination by parthenolide recruits the plant-specific kinesin KCH to cortical microtubules.
Schneider N; Ludwig H; Nick P
J Exp Bot; 2015 Apr; 66(7):2001-11. PubMed ID: 25779700
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo.
Zhang D; Qiu L; Jin X; Guo Z; Guo C
Mol Cancer Res; 2009 Jul; 7(7):1139-49. PubMed ID: 19584264
[TBL] [Abstract][Full Text] [Related]
7. Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends.
Peris L; Thery M; Fauré J; Saoudi Y; Lafanechère L; Chilton JK; Gordon-Weeks P; Galjart N; Bornens M; Wordeman L; Wehland J; Andrieux A; Job D
J Cell Biol; 2006 Sep; 174(6):839-49. PubMed ID: 16954346
[TBL] [Abstract][Full Text] [Related]
8. Assembly and colchicine binding characteristics of tubulin with maximally tyrosinated and detyrosinated alpha-tubulins.
Skoufias DA; Wilson L
Arch Biochem Biophys; 1998 Mar; 351(1):115-22. PubMed ID: 9500839
[TBL] [Abstract][Full Text] [Related]
9. Parthenolide Destabilizes Microtubules by Covalently Modifying Tubulin.
Hotta T; Haynes SE; Blasius TL; Gebbie M; Eberhardt EL; Sept D; Cianfrocco M; Verhey KJ; Nesvizhskii AI; Ohi R
Curr Biol; 2021 Feb; 31(4):900-907.e6. PubMed ID: 33482110
[TBL] [Abstract][Full Text] [Related]
10. Suppression of the NF-kappaB signalling pathway by ergolide, sesquiterpene lactone, in HeLa cells.
Chun JK; Seo DW; Ahn SH; Park JH; You JS; Lee CH; Lee JC; Kim YK; Han JW
J Pharm Pharmacol; 2007 Apr; 59(4):561-6. PubMed ID: 17430640
[TBL] [Abstract][Full Text] [Related]
11. Sesquiterpene lactone parthenolide ameliorates bladder inflammation and bladder overactivity in cyclophosphamide induced rat cystitis model by inhibiting nuclear factor-kappaB phosphorylation.
Kiuchi H; Takao T; Yamamoto K; Nakayama J; Miyagawa Y; Tsujimura A; Nonomura N; Okuyama A
J Urol; 2009 May; 181(5):2339-48. PubMed ID: 19303104
[TBL] [Abstract][Full Text] [Related]
12. Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappaB and split-dose repair.
Mendonca MS; Chin-Sinex H; Gomez-Millan J; Datzman N; Hardacre M; Comerford K; Nakshatri H; Nye M; Benjamin L; Mehta S; Patino F; Sweeney C
Radiat Res; 2007 Dec; 168(6):689-97. PubMed ID: 18088190
[TBL] [Abstract][Full Text] [Related]
13. Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB.
Siedle B; García-Piñeres AJ; Murillo R; Schulte-Mönting J; Castro V; Rüngeler P; Klaas CA; Da Costa FB; Kisiel W; Merfort I
J Med Chem; 2004 Nov; 47(24):6042-54. PubMed ID: 15537359
[TBL] [Abstract][Full Text] [Related]
14. Suppression of nuclear oscillations in Saccharomyces cerevisiae expressing Glu tubulin.
Badin-Larçon AC; Boscheron C; Soleilhac JM; Piel M; Mann C; Denarier E; Fourest-Lieuvin A; Lafanechère L; Bornens M; Job D
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5577-82. PubMed ID: 15031428
[TBL] [Abstract][Full Text] [Related]
15. Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors.
Kobayashi M; Wakabayashi I; Suzuki Y; Fujiwara K; Nakayama M; Watabe T; Sato Y
Angiogenesis; 2021 Feb; 24(1):159-176. PubMed ID: 33052495
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of tubulin tyrosine ligase: a potential mechanism for regulation of alpha-tubulin tyrosination.
Idriss HT
Cell Motil Cytoskeleton; 2000 May; 46(1):1-5. PubMed ID: 10842328
[TBL] [Abstract][Full Text] [Related]
17. Post-translational incorporation of the antiproliferative agent azatyrosine into the C-terminus of alpha-tubulin.
Purro SA; Bisig CG; Contin MA; Barra HS; Arce CA
Biochem J; 2003 Oct; 375(Pt 1):121-9. PubMed ID: 12852782
[TBL] [Abstract][Full Text] [Related]
18. Antimyeloma effects of a sesquiterpene lactone parthenolide.
Suvannasankha A; Crean CD; Shanmugam R; Farag SS; Abonour R; Boswell HS; Nakshatri H
Clin Cancer Res; 2008 Mar; 14(6):1814-22. PubMed ID: 18347184
[TBL] [Abstract][Full Text] [Related]
19. Production and utilization of detyrosinated tubulin in developing Artemia larvae: evidence for a tubulin-reactive carboxypeptidase.
Xiang H; MacRae TH
Biochem Cell Biol; 1995; 73(9-10):673-85. PubMed ID: 8714688
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological profiling of parthenolide ether analogs.
Freund RRA; Gobrecht P; Moser P; Fischer D; Arndt HD
Org Biomol Chem; 2019 Dec; 17(45):9703-9707. PubMed ID: 31701984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
